Lyndhurst, NJ – In a recent article by the executive chairman of Vitals, Mitch Rothschild wrote about what is being done to measure the quality in healthcare, but more specifically how that effects patients. He makes a strong case that outcomes should be the measure of healthcare quality.

Last year Vitals held a survey asking people one question, “What is most important to you when selecting a primary care doctor?” The results reflects many of our current 2016 health trends (download here).

Why this matters:

The current climate in health insurance makes it no surprise that Vitals recorded 63 percent of people surveyed believed that accepting their insurance was the largest factor when choosing a doctor. Location was second with 36.6 percent, and online reviews were touched on in several other higher ranking responses. Patients are choosing doctors with new tools and for new reasons, but it all centers around the total experience they will have when visiting the doctor.

Check out the article and results from the survey here.

About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.